» Articles » PMID: 31291271

Independent Factors Associate with Hospital Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Intensive Care Unit Admission: Focusing on the Eosinophil-to-neutrophil Ratio

Overview
Journal PLoS One
Date 2019 Jul 11
PMID 31291271
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Factors associated with hospital mortality are unclear in patients with acute exacerbation of COPD (AECOPD) requiring intensive care unit (ICU) admission. We aimed to characterize these patients and identify factors associated with hospital mortality.

Patients And Methods: We used a retrospective observational case-control design and recruited patients between January 2015 and March 2017. Of 146 patients enrolled, 24 (16.4%) died during their hospital stay, while 122 survived.

Results: Multivariate logistic regression analyses revealed factors associated with hospital mortality: age (adjusted odds ratio [AOR] 1.12, 95% CI: 1.03-1.23), C-reactive protein (CRP) level >7.5 mg/dL at the emergency room (AOR 4.52, 95% CI: 1.27-16.04), peak eosinophil-to-neutrophil ratio (ENR)×102 on days 8-14 of treatment (AOR 0.22, 95% CI: 0.08-0.63), and in-hospital complications (AOR 4.23, 95% CI: 1.12-15.98) (all P<0.05). After receiver operating characteristic curve analyses, cutoff level for peak ENR×102 was 0.224. To examine the synergistic effects of CRP level and peak ENR, we divided patients into four groups: (G0, reference group) Peak ENR×102 >0.224 on days 8-14 and initial CRP <7.5 mg/dL; (G1) Peak ENR×102 >0.224 on days 8-14 and initial CRP >7.5 mg/dL; (G2) Peak ENR×102 <0.224 on days 8-14 and initial CRP <7.5 mg/dL; and (G3) Peak ENR×102 <0.224 on days 8-14 and initial CRP >7.5 mg/dL. For G2 and G3 patients, the AOR of mortality was significantly different from that of the reference group (G2: AOR 10.00, P = 0.020; G3: AOR 61.79, P<0.001). The relationship between 28-day mortality and the four groups was statistically significant (log-rank test, P<0.001).

Conclusion: Older age, initial CRP >7.5 mg/dL, peak ENR on days 8-14, and in-hospital complications were associated with hospital mortality in patients with AECOPD requiring ICU admission. Patients with both biomarkers, initial CRP >7.5 mg/dL, and peak ENR×102 <0.224 on days 8-14 of treatment, had an increased risk of hospital mortality.

Citing Articles

Eosinophil count and clinical outcome in patients with acute exacerbation of Chronic obstructive pulmonary disease.

Faraji N, Hussain Bhat I, Akrami M, Hosamirudsari H, Kazemizadeh H, Naderi A J Prev Med Hyg. 2025; 65(3):E389-E394.

PMID: 39758767 PMC: 11698108. DOI: 10.15167/2421-4248/jpmh2024.65.3.3267.


Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP).

Cui X, Xie B, Zhu K, Liao Q, Zhou J, Du S Sci Rep. 2024; 14(1):30406.

PMID: 39638829 PMC: 11621349. DOI: 10.1038/s41598-024-80727-1.


Intestinal dysbiosis as an intraoperative predictor of septic complications: evidence from human surgical cohorts and preclinical models of peritoneal sepsis.

Spari D, Zwicky S, Yilmaz B, Salm L, Candinas D, Beldi G Sci Rep. 2023; 13(1):22921.

PMID: 38129468 PMC: 10739899. DOI: 10.1038/s41598-023-49034-z.


Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms?.

Crocetto F, Imbimbo C, Barone B, Turchino D, Bracale U, Peluso A Basic Clin Androl. 2023; 33(1):38.

PMID: 38110896 PMC: 10729439. DOI: 10.1186/s12610-023-00213-y.


The Prognostic Value of Blood Eosinophil Level in AECOPD is Influenced by Corticosteroid Treatment During Hospitalization.

Li J, Liang L, Feng L, Cao S, Samuel Cai Y, Li X J Inflamm Res. 2023; 16:3233-3243.

PMID: 37555013 PMC: 10404713. DOI: 10.2147/JIR.S421605.


References
1.
Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. DOI: 10.1056/NEJMoa0909883. View

2.
Barnes P . Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016; 138(1):16-27. DOI: 10.1016/j.jaci.2016.05.011. View

3.
Handzel Z, Busse W, Sedgwick J, Vrtis R, Lee W, Kelly E . Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol. 1998; 160(3):1279-84. View

4.
Knaus W, Draper E, Wagner D, Zimmerman J . APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-29. View

5.
Kang H, Rhee C, Kim S, Kim J, Lee S, Yoon H . Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:2467-2473. PMC: 5055104. DOI: 10.2147/COPD.S116072. View